SAN FRANCISCO – A week after disclosing the successful completion of an initial research goal and extending its partnership with Evotec AG, newco Padlock Therapeutics Inc. landed at the 33rd Annual J.P. Morgan (JPM) Healthcare Conference with its veteran CEO juggling "a full dance card" of partnering meetings.